| Medical and Health Sciences | 2021-2025 | 549 | US 191 | 99.88 |
| Reproductive Medicine | Lifetime | 75 | US 32 | 99.55 |
| Public, Environmental and Occupational Health | Lifetime | 411 | US 206 | 99.42 |
| Pediatrics, Perinatology and Child Health | Lifetime | 256 | US 122 | 99.28 |
| Obstetrics and Gynecology | Lifetime | 182 | US 83 | 98.85 |
| Health, Toxicology and Mutagenesis | Lifetime | 925 | US 326 | 95.14 |
| Public, Environmental and Occupational Health | 2021-2025 | 80 | US 30 | 99.34 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 67 | US 23 | 98.97 |
| Reproductive Medicine | 2021-2025 | 46 | US 11 | 98.98 |
| Obstetrics and Gynecology | 2021-2025 | 98 | US 34 | 97.58 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 317 | US 76 | 94.73 |
| Ovarian function and disorders | Lifetime | 67 | US 24 | 99.57 |
| Assisted Reproductive Technology and Twin Pregnancy | Lifetime | 56 | US 21 | 99.38 |
| Birth, Development, and Health | Lifetime | 177 | US 68 | 99.31 |
| Gestational Diabetes Research and Management | Lifetime | 70 | US 30 | 99.31 |
| Reproductive Health and Technologies | Lifetime | 102 | US 49 | 98.81 |
| Pregnancy and preeclampsia studies | Lifetime | 413 | US 161 | 98.51 |
| Nutritional Studies and Diet | Lifetime | 401 | US 161 | 98.61 |
| Sperm and Testicular Function | Lifetime | 363 | US 131 | 98.40 |
| Reproductive Biology and Fertility | Lifetime | 650 | US 231 | 98.14 |
| Cancer, Lipids, and Metabolism | Lifetime | 696 | US 336 | 97.55 |
| Fatty Acid Research and Health | Lifetime | 411 | US 159 | 97.02 |
| Endometriosis Research and Treatment | Lifetime | 891 | US 269 | 96.04 |
| Cancer Risks and Factors | Lifetime | 956 | US 490 | 94.01 |
| Male Reproductive Health Studies | Lifetime | 252 | US 101 | 91.19 |
| Menstrual Health and Disorders | Lifetime | 495 | US 205 | 86.13 |
| Safe Handling of Antineoplastic Drugs | Lifetime | 323 | US 101 | 77.81 |
| Birth, Development, and Health | 2021-2025 | 28 | US 13 | 99.02 |
| Gestational Diabetes Research and Management | 2021-2025 | 15 | US 7 | 98.90 |
| Ovarian function and disorders | 2021-2025 | 34 | US 4 | 98.71 |
| Assisted Reproductive Technology and Twin Pregnancy | 2021-2025 | 59 | US 12 | 97.23 |
| Nutritional Studies and Diet | 2021-2025 | 193 | US 46 | 97.12 |
| Pregnancy and preeclampsia studies | 2021-2025 | 256 | US 73 | 95.97 |
| Reproductive Health and Technologies | 2021-2025 | 92 | US 48 | 95.76 |
| Obesity, Physical Activity, Diet | 2021-2025 | 403 | US 106 | 95.93 |
| Reproductive Biology and Fertility | 2021-2025 | 524 | US 85 | 92.86 |
| Effects and risks of endocrine disrupting chemicals | 2021-2025 | 344 | US 66 | 90.90 |
| Endometriosis Research and Treatment | 2021-2025 | 468 | US 69 | 90.96 |
| Breastfeeding Practices and Influences | 2021-2025 | 344 | US 94 | 87.96 |
| Cancer Risks and Factors | 2021-2025 | 692 | US 245 | 78.81 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 873 | US 391 | 76.95 |
| Menstrual Health and Disorders | 2021-2025 | 231 | US 52 | 73.35 |
| Consumer Attitudes and Food Labeling | 2021-2025 | 987 | US 177 | 72.01 |
| Demographic Trends and Gender Preferences | 2021-2025 | 476 | US 98 | 51.75 |
| Phytoestrogen effects and research | 2021-2025 | 889 | US 90 | 48.24 |
